Biosimilar bidding in centralized tenders in Norway
Our objective is to study the competition effect of biosimilar entry in centralized tenders for an expensive category or drugs - TNF-inhibitors. We use monthly observations of prices and volumes for all brands and biosimilars in this drug category in Norway, covering the period from Jan. 2006 to De...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Oslo
2021-01-01
|
Series: | Nordic Journal of Health Economics |
Subjects: | |
Online Access: | https://journals.uio.no/NJHE/article/view/7394 |